The Importance of Clinical Trials in Infertility

Opinion
Video

Jeffrey Dunn, Pharm.D., MBA, discusses how comparison trials for different assisted reproductive technologies (ARTs) are necessary to evaluate their relative efficacy, safety and cost-effectiveness, with specific focus on a trial comparing highly purified human menotropin (HP-hMG) and recombinant follicle-stimulating hormone (FSH), as well as a study examining the impact of health benefit design for ART on pregnancy outcomes.

Video content above is prompted by the following:

  • Why is it necessary to have comparison trials for the different assisted reproductive technologies (ARTs) that are used in clinical practice?
  • What was seen in the trial that compared highly purified human menotropin (HP-hMG) and recombinant follicle-stimulating hormone (FSH), and how do these results affect your decision-making?
  • What was seen in a study that examined health benefit design for ART and its impact on pregnancy outcomes?
Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.